商品簡介
The nature of the disease in breast cancer, as well as its intensive treatment regimens, increases the risk of various side effects-both physical and mental and emotional-that impair survivors' quality of life.Today, assessing quality of life has become a major focus in the management of cancer. Standardized questionnaires such as the EORTC QLQ-C30 and QLQ-BR45 are among the most reliable measurement tools for quantifying and qualifying the QoL of patients in remission from cancer.In this context, we conducted a descriptive and analytical cross-sectional study between January 2019 and December 2021 on the QoL of 106 women in remission from breast cancer in order to describe the sociodemographic, clinical, and treatment characteristics of the patients by estimating their QoL and to examine the interaction between these parameters and the functional and symptomatic scales of QoL.
